Comparison

(R)-JAK2/STAT3-IN-1 European Partner

Item no. HY-167839-10mg
Manufacturer MedChem Express
CASRN 2485758-49-2
Amount 10 mg
Quantity options 1 ea 10 mg 1 mg 25 mg 5 mg
Category
Type Standard
Specific against other
Citations [1]Discovery of bazedoxifene analogues targeting glycoprotein 130
Smiles NC(N1[C@H](CC(C2=CC=C(C=C2)C(F)(F)F)=N1)C(C3=C4)=CN(CC5=CC=C(C=C5)OCCN6CCCCCC6)C3=CC=C4Br)=O
ECLASS 10.1 42021590
ECLASS 11.0 42021590
UNSPSC 12352202
Shipping condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
Apoptosis
Shipping Temperature
Room temperature
Molecular Weight
682.57
Product Description
(R)-JAK2/STAT3-IN-1 is a GP130 D1 domain inhibitor with anti-tumor activity. (R)-JAK2/STAT3-IN-1 can inhibit the phosphorylation of JAK2 and STAT3. The affinity of (R)-JAK2/STAT3-IN-1 for GP130 protein is 3.8 μM. (R)-JAK2/STAT3-IN-1 effectively inhibits the viability and migration of tumor cells and promotes apoptosis [1] .
Manufacturer - Research Area
Cancer
Manufacturer - Pathway
Apoptosis
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close